These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25088081)

  • 1. Driving under the influence of synthetic cannabinoid receptor agonist XLR-11.
    Lemos NP
    J Forensic Sci; 2014 Nov; 59(6):1679-83. PubMed ID: 25088081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case reports of synthetic cannabinoid XLR-11 associated fatalities.
    Shanks KG; Winston D; Heidingsfelder J; Behonick G
    Forensic Sci Int; 2015 Jul; 252():e6-9. PubMed ID: 25979131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of suspected cases of driving under the influence of drugs (DUID) involved in traffic accidents in Istanbul (Turkey).
    Acar F; Asirdizer M; Aker RG; Kucukibrahimoglu EE; Ates I; Erol Y; Sahin A
    J Forensic Leg Med; 2013 Aug; 20(6):626-31. PubMed ID: 23910848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
    Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
    Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Driving Associated with the Synthetic Cannabinoid 5f-Adb.
    McCain KR; Jones JO; Chilbert KT; Patton AL; James LP; Moran JH
    J Forensic Sci Criminol; 2018 Aug; 6(1):. PubMed ID: 30956998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XLR-11 and UR-144 in Washington state and state of Alaska driving cases.
    Louis A; Peterson BL; Couper FJ
    J Anal Toxicol; 2014 Oct; 38(8):563-8. PubMed ID: 25217547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood synthetic cannabinoid concentrations in cases of suspected impaired driving.
    Yeakel JK; Logan BK
    J Anal Toxicol; 2013 Oct; 37(8):547-51. PubMed ID: 23965292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Synthetic Cannabinoid UR-144 on Human Psychomotor Performance--A Case Report Demonstrating Road Traffic Risks.
    Adamowicz P; Lechowicz W
    Traffic Inj Prev; 2015; 16(8):754-9. PubMed ID: 25794331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine.
    Mohr AL; Ofsa B; Keil AM; Simon JR; McMullin M; Logan BK
    J Anal Toxicol; 2014 Sep; 38(7):427-31. PubMed ID: 24908262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polydrug intoxication involving methoxetamine in a drugs and driving case.
    Elian AA; Hackett J
    J Forensic Sci; 2014 May; 59(3):854-8. PubMed ID: 24528118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
    Ammann J; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers.
    Anzillotti L; Castrignanò E; Strano Rossi S; Chiarotti M
    Sci Justice; 2014 Dec; 54(6):421-6. PubMed ID: 25498928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Analysis of Synthetic Cannabinoid Metabolites in Urine of Individuals Suspected of Driving Impaired.
    Davies BB; Bayard C; Larson SJ; Zarwell LW; Mitchell RA
    J Anal Toxicol; 2016 Mar; 40(2):89-96. PubMed ID: 26687103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework.
    Krotulski AJ; Mohr ALA; Diamond FX; Logan BK
    Drug Test Anal; 2020 Jan; 12(1):136-144. PubMed ID: 31788963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use.
    Paul ABM; Simms L; Amini S; Paul AE
    J Forensic Sci; 2018 Jul; 63(4):1321-1324. PubMed ID: 29194599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of synthetic cannabinoids in serum samples--epidemiology and consumption patterns.
    Jaenicke NJ; Pogoda W; Paulke A; Wunder C; Toennes SW
    Forensic Sci Int; 2014 Sep; 242():81-87. PubMed ID: 25050839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results.
    Marinetti LJ; Antonides HM
    J Anal Toxicol; 2013 Apr; 37(3):135-46. PubMed ID: 23361867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine.
    Kanamori T; Kanda K; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    Drug Test Anal; 2015 Apr; 7(4):341-5. PubMed ID: 25600155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death after use of the synthetic cannabinoid 5F-AMB.
    Shanks KG; Behonick GS
    Forensic Sci Int; 2016 May; 262():e21-4. PubMed ID: 27017174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.